Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew J Muir

Showing results (121-130 of 187) with videos related to

Pageof 19
Sort By:
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|January 29, 2026
Evolution of Out-of-Sequence Liver Allocation, 2019-2024Jacqueline B Henson, Xuyang Xia, Ryan McDevitt, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|May 20, 2003
De-novo cholangiocarcinoma in the setting of recurrent primary sclerosing cholangitis following liver transplantMichael A Heneghan, J Elizabeth Tuttle-Newhall, Paul V Suhocki, et al.
Clinical Imaging|May 3, 2021
Proton pump inhibitor use is associated with increased rates of post-TIPS hepatic encephalopathy: Replication in an independent patient cohortRui Dai, Alan A Sag, Jonathan G Martin, et al.
The American Journal of Gastroenterology|January 26, 2005
Erythropoietic response to anemia in chronic hepatitis C patients receiving combination pegylated interferon/ribavirinVijayan Balan, David Schwartz, George Y Wu, et al.
Hepatology Communications|September 12, 2018
NGM282 for Treatment of Patients With Primary Biliary Cholangitis: A Multicenter, Randomized, Double-Blind, Placebo-Controlled TrialMarlyn J Mayo, Alan J Wigg, Barbara A Leggett, et al.
Journal of the National Medical Association|October 2, 2013
The hepatitis C crisis in the African American Community: findings and recommendationsRahn K Bailey, Andrew J Muir, Charles D Howell, et al.
Hepatology (Baltimore, Md.)|February 10, 2012
Hepatitis C virus selectively perturbs the distal cholesterol synthesis pathway in a genotype-specific mannerPaul J Clark, Alexander J Thompson, David M Vock, et al.
Journal of Hepatology|June 28, 2011
Beneficial IL28B genotype associated with lower frequency of hepatic steatosis in patients with chronic hepatitis CHans L Tillmann, Keyur Patel, Andrew J Muir, et al.
Hepatology (Baltimore, Md.)|March 18, 2010
Interferon-lambda genotype and low serum low-density lipoprotein cholesterol levels in patients with chronic hepatitis C infectionJosephine H Li, Xiang Qian Lao, Hans L Tillmann, et al.
Gastroenterology|August 1, 2017
Baseline Parameters in Clinical Trials for Nonalcoholic Steatohepatitis: Recommendations From the Liver ForumYuval A Patel, Joanne C Imperial, Andrew J Muir, et al.
Pageof 19

Showing results (121-130 of 187) with videos related to

Sort By:
Pageof 19
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|January 29, 2026
Evolution of Out-of-Sequence Liver Allocation, 2019-2024Jacqueline B Henson, Xuyang Xia, Ryan McDevitt, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|May 20, 2003
De-novo cholangiocarcinoma in the setting of recurrent primary sclerosing cholangitis following liver transplantMichael A Heneghan, J Elizabeth Tuttle-Newhall, Paul V Suhocki, et al.
Clinical Imaging|May 3, 2021
Proton pump inhibitor use is associated with increased rates of post-TIPS hepatic encephalopathy: Replication in an independent patient cohortRui Dai, Alan A Sag, Jonathan G Martin, et al.
The American Journal of Gastroenterology|January 26, 2005
Erythropoietic response to anemia in chronic hepatitis C patients receiving combination pegylated interferon/ribavirinVijayan Balan, David Schwartz, George Y Wu, et al.
Hepatology Communications|September 12, 2018
NGM282 for Treatment of Patients With Primary Biliary Cholangitis: A Multicenter, Randomized, Double-Blind, Placebo-Controlled TrialMarlyn J Mayo, Alan J Wigg, Barbara A Leggett, et al.
Journal of the National Medical Association|October 2, 2013
The hepatitis C crisis in the African American Community: findings and recommendationsRahn K Bailey, Andrew J Muir, Charles D Howell, et al.
Hepatology (Baltimore, Md.)|February 10, 2012
Hepatitis C virus selectively perturbs the distal cholesterol synthesis pathway in a genotype-specific mannerPaul J Clark, Alexander J Thompson, David M Vock, et al.
Journal of Hepatology|June 28, 2011
Beneficial IL28B genotype associated with lower frequency of hepatic steatosis in patients with chronic hepatitis CHans L Tillmann, Keyur Patel, Andrew J Muir, et al.
Hepatology (Baltimore, Md.)|March 18, 2010
Interferon-lambda genotype and low serum low-density lipoprotein cholesterol levels in patients with chronic hepatitis C infectionJosephine H Li, Xiang Qian Lao, Hans L Tillmann, et al.
Gastroenterology|August 1, 2017
Baseline Parameters in Clinical Trials for Nonalcoholic Steatohepatitis: Recommendations From the Liver ForumYuval A Patel, Joanne C Imperial, Andrew J Muir, et al.
Pageof 19